Dengue IgM – Elisa

Dengue fever represents a pressing global health challenge, swiftly emerging as a pervasive infectious disease. Hypro Diagnostics, in alignment with the World Health Organization’s findings across more than 100 countries as reported by the Centers for Disease Control and Prevention, recognizes the urgency surrounding this viral threat. Characterized by an abrupt onset of high fever and flu-like symptoms within 4 to 7 days post-mosquito exposure, dengue’s progression includes severe manifestations such as intense headaches, joint and muscle pain, vomiting, nausea, skin rash, and swollen glands. Swift and effective diagnostic measures, such as those provided by Hypro Diagnostics, are pivotal in addressing and mitigating the potential fatality associated with this escalating global health concern.